Basics Pfizer Inc. Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $141.46B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 0.89% Avg Daily Range (30 D): $0.22 | 0.89% Avg Daily Range (90 D): $0.25 | 1.02% Institutional Daily Volume Avg Daily Volume: 30.44M Avg Daily Volume (30 D): 36.01M Avg Daily Volume (90 D): 35.96M Trade Size Avg Trade Size (Sh.): 310 Avg Trade Size (Sh.) (30 D): 273 Avg Trade Size (Sh.) (90 D): 276 Institutional Trades Total Inst.Trades: 361,464 Avg Inst. Trade: $3.48M Avg Inst. Trade (30 D): $4.75M Avg Inst. Trade (90 D): $4.68M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 65 Market Closing Trades Avg Closing Trade: $80.26M Avg Closing Trade (30 D): $98.01M Avg Closing Trade (90 D): $114.87M Avg Closing Volume: 2.49M     News Sep 7, 2025 @ 3:14 PM Think It's Too Late to Buy This Leading Biotech St... Source: Lee Samaha Sep 7, 2025 @ 1:30 PM Is Pfizer a Millionaire Maker? Source: Reuben Gregg Brewer Sep 5, 2025 @ 8:10 AM Down 34%, Should You Buy the Dip on Viking Therape... Source: Adria Cimino Sep 4, 2025 @ 3:00 PM Australia Acute Respiratory Distress Syndrome Mark... Source: Researchandmarkets.Com Sep 4, 2025 @ 3:00 PM Monoclonal Antibodies Therapeutics Market Size Pro... Source: Towards Healthcare Financials   TTM Q2 2025 Q1 2025 Basic EPS $1.89 $.51 $.52 Diluted EPS $1.88 $.51 $.52 Revenue $ 63.83B $ 14.65B $ 13.72B Gross Profit $ 46.04B $ 10.88B $ 10.87B Net Income / Loss $ 10.79B $ 2.93B $ 2.97B Operating Income / Loss $ 10.53B $ 3.04B $ 2.79B Cost of Revenue $ 17.8B $ 3.78B $ 2.85B Net Cash Flow $ 574M $ 214M $ 375M PE Ratio 13.22